ICRS-PAT 2021

Targeted nanovaccine as a powerfull platform to improve immune modulation and checkpoint therapies

Helena Florindo
Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy, University of Lisbon, Portugal

N/A









Powered by Eventact EMS